Accelmed is dedicated to advancing healthcare technology, focusing on medical devices, tools and diagnostics, digital health, and tech-enabled services. The company employs a private equity approach to support and improve healthcare businesses, aiming to enhance patient care and treatment outcomes through innovative healthtech solutions.
We're tracking Accelmed's market expansion
How Accelmed's international expansion compares to its competitors
AccelmedYouBars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AccelmedYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
Boston Scientific acquires Israeli medical device company SoniVie for up to $540 million, gaining intravascular ultrasound technology for treating high blood pressure.
Acclaro Medical secures $23M in Series B funding led by Accelmed Partners with 3E Bioventures Capital for innovation and global expansion.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Accelmed's business, markets, and growth signals.
Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.
© 2026 Pubrio. All rights reserved.
